Tomocube, Inc. (KOSDAQ:475960)

South Korea flag South Korea · Delayed Price · Currency is KRW
53,800
-800 (-1.47%)
At close: Apr 28, 2026
206.73%
Market Cap 730.73B
Revenue (ttm) 11.31B
Net Income (ttm) -4.81B
Shares Out 13.38M
EPS (ttm) -365.00
PE Ratio n/a
Forward PE 201.48
Dividend n/a
Ex-Dividend Date n/a
Volume 50,936
Average Volume 73,951
Open 54,500
Previous Close 54,600
Day's Range 53,300 - 55,300
52-Week Range 16,120 - 67,800
Beta n/a
RSI 47.56
Earnings Date Apr 3, 2026

About Tomocube

Tomocube, Inc. engages in the manufacture and sale of optical devices and medical equipment. Its holotomography (HT) products include HT-X1 for live-cell imaging and analysis; and HT-2H for 3D live cell imaging. The company also offers TomoAnalysis, a 3D image visualization and analysis software. In addition, it provides accessories, such as HT-ready 96 well plates; TomoDish that is designed to accommodate both adherent and suspension cells; TomoChamber, a stage-top incubator designed for long-term live cell imaging; TomoPlate, an active vibrat... [Read more]

Industry Laboratory Apparatus and Furniture
Founded 2015
Country South Korea
Stock Exchange KOSDAQ
Ticker Symbol 475960
Full Company Profile

Financial Performance

In 2025, Tomocube's revenue was 11.31 billion, an increase of 90.39% compared to the previous year's 5.94 billion. Losses were -4.81 billion, -42.06% less than in 2024.

Financial Statements

News

There is no news available yet.